NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Wednesday, May 9th. Stockholders of record on Monday, July 2nd will be given a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 annualized dividend and a dividend yield of 3.52%. The ex-dividend date is Friday, June 29th. This is a boost from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health announced that its board has approved a share repurchase plan on Thursday, February 8th 2018, which permits the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) posted its quarterly earnings data on Thursday, May, 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts' consensus estimates of $1.51 by $0.12. The business had revenue of $33.63 billion for the quarter, compared to analysts' expectations of $33.61 billion. Cardinal Health had a net margin of 1.26% and a return on equity of 23.39%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus estimate of $5.42.

15 equities research analysts have issued 1 year price targets for Cardinal Health's shares. Their predictions range from $55.00 to $85.00. On average, they expect Cardinal Health's stock price to reach $69.7692 in the next year. View Analyst Ratings for Cardinal Health.

Cardinal Health saw a decline in short interest in the month of May. As of May 15th, there was short interest totalling 9,109,975 shares, a decline of 33.6% from the April 30th total of 13,723,348 shares. Based on an average daily volume of 5,195,453 shares, the short-interest ratio is presently 1.8 days. Currently, 2.9% of the company's shares are short sold.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

News headlines about CAH stock have been trending positive on Wednesday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardinal Health earned a coverage optimism score of 0.30 on Accern's scale. They also gave media stories about the company an impact score of 45.87 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Cardinal Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.73%), Barrow Hanley Mewhinney & Strauss LLC (5.98%), American International Group Inc. (2.51%), Boston Partners (1.94%), Franklin Resources Inc. (1.81%) and Northern Trust Corp (1.37%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Element Capital Management LLC, Franklin Resources Inc., JPMorgan Chase & Co., American Century Companies Inc., BlackRock Inc., Thompson Siegel & Walmsley LLC, LSV Asset Management and DekaBank Deutsche Girozentrale. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was acquired by a variety of institutional investors in the last quarter, including Boston Partners, Pzena Investment Management LLC, Point72 Asset Management L.P., Schwab Charles Investment Management Inc., Barrow Hanley Mewhinney & Strauss LLC, Russell Investments Group Ltd., Wedge Capital Management L L P NC and Roystone Capital Management LP. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $54.10.

Cardinal Health has a market capitalization of $16.47 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]